Line of Credit, Long-Term Debt and Finance Lease Obligations (Tables)

12 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

The carrying value of the Company’s long-term debt was $622.2 million and $637.2 million at December 31, 2023 and 2022, respectively, and consisted of the following (in thousands):

	December 31, 2023
	Principal		Unamortized Debt Issuance Costs			Total
Senior notes	$	400,000	$	(4,354	)	$	395,646
Revolving line of credit		—		(1,006	)		(1,006	)
Term A loan		228,125		(559	)		227,566
Total	$	628,125	$	(5,919	)	$	622,206

	December 31, 2022
	Principal		Unamortized Debt Issuance Costs			Total
Senior notes	$	400,000	$	(5,069	)	$	394,931
Revolving line of credit		4,000		(1,489	)		2,511
Term A loan		240,625		(827	)		239,798
Total	$	644,625	$	(7,385	)	$	637,240

Summary of Estimated Fair Value of Notes

The estimated fair value of the Company’s 2030 Notes was estimated using trading prices as of December 31, 2023 and 2022, respectively, as Level 2 inputs to estimate fair value for relevant periods and are summarized as follows (in thousands):

	December 31,
	2023		2022
2030 Notes		357,000		344,000

Schedule of Financial Lease Obligations

The Company redeemed the full principal balance of its 2027 Notes in February 2022.

The Company’s finance lease obligations, primarily related to equipment used in its newborn hearing screen program, consist of the following (in thousands):

	December 31,
	2023			2022
Finance lease obligations	$	9,241		$	11,128
Less: Current portion		(2,413	)		(2,398	)
Long-term portion	$	6,828		$	8,730